Foresite Capital Management Iv, LLC Relay Therapeutics, Inc. Transaction History

Foresite Capital Management Iv, LLC

  • $149 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$29.75 - $37.99 $16.6 Million - $21.1 Million
-556,380 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$27.5 - $38.19 $43.5 Million - $60.5 Million
-1,583,000 Reduced 73.99%
556,380 $20.4 Million
Q3 2020

Nov 13, 2020
BUY
$32.81 - $45.1 $70.2 Million - $96.5 Million
2,139,380 New
2,139,380 $91.1 Million

Others Institutions Holding RLAY

# of Institutions
180
Shares Held
127M
Call Options Held
16.7K
Put Options Held
18K
View Full List

About Relay Therapeutics, Inc.

RLAY Quotes by TradingView
  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $678M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Foresite Capital Management Iv, LLC Portfolio

Follow Foresite Capital Management Iv, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iv, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foresite Capital Management Iv, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email